High long-term survival rates for postop PCa patients — 5 key points

In a study published in Urologic Oncology, researchers found long-term survival of young men who undergo radical prostatectomy for high-risk prostate cancer is highly satisfactory.

Advertisement

Paolo Dell’Oglio, MD, of the Urological Research Institute, IRCCS Ospedale San Raffele in Milan, Italy, was the study’s leading physician. Dr. Dell’Oglio and colleagues studied 600 men aged 59 years or younger.

Here are five key points:

1. Researchers found the 10-, 15- and 20-year cancer-specific mortality rates were 11.6 percent, 15.5. percent and 13.5. percent, respectively.

2. The 10-, 15- and 20-year other-cause mortality rates were 5.5 percent, 13.5 percent and 19.3 percent respectively.

3. Dr. Dell’Oglio’s team determined the five-year probability of CSM and OCM among patients who survived five, 10 and 15 years after surgery was 6.4 percent and 2.7 percent versus 4.6 percent and 9.6 percent versus 4.2 percent and 8.2 percent, respectively.

4. Major determinants of CSM included year of surgery, pathologic stage and Gleason score, surgical margin status and lymph node invasion.

5. PCa is the leading cause of death during the first 10 years of post-RP survivorship.

More articles on healthcare:
This outpatient surgery center is also an ‘idea center’ — 5 things to know
Kidney injury common following vascular surgery — 3 key points
Primary care physicians to lose 10% Medicare bonus — 5 takeaways

Advertisement

Next Up in ASC News

  • Becker’s reported on 39 hospital mergers and acquisitions in 2025, ranging from rural hospital partnerships to massive, multi-state system expansions. …

  • Brewer, Maine-based Northern Light Health will close its primary care practice in Castine on Feb. 27, citing staffing challenges, declining…

  • The dynamics shaping mergers and acquisitions within the ASC space are constantly shifting as corporate entities push consolidation efforts and…

Advertisement

Comments are closed.